Problem

Kabilah addresses a high-risk, fragmented problem in inpatient nursing: nurses must continuously reconstruct changing patient conditions, medications, labs, care plans, and interdisciplinary updates, often across paper report sheets, verbal handoffs, and repetitive EHR documentation. The killer use case is shift change, where missing or inaccurate context can delay escalation, create preventable complications, extend length of stay, and increase avoidable hospital spending. The same administrative and communication burden contributes to nurse burnout and turnover, making the problem both a patient-safety issue and an operating-cost issue for hospitals.

Product / Service

Kabilah is an enterprise-grade, HIPAA-compliant AI platform for nursing workflows. It replaces fragmented paper reports with digital patient advocates that can be customized to show pertinent information, optionally populated from the EHR, and intelligently summarized for the next nurse. The broader platform supports complete verbal handoffs, voice-to-text capture, context-aware task lists, and export of report information into EHR notes and flowsheets, reducing redundant charting while keeping nurses focused on patient care.

The delivery model is enterprise software sold to hospitals and health systems, with compatibility across major EHRs through standard FHIR protocols. Kabilah says deployments can go live in two to four weeks and include security controls, encryption, onsite support, governance customization, and an analytics portal for monitoring usage and nursing-quality metrics.

Market

Kabilah competes in HealthTech and healthcare IT, specifically the emerging category of nursing-focused clinical workflow, care-team coordination, and generative-AI software for hospitals and health systems. Publicly identified alternatives include Meditech, Qventus, and TigerConnect, while Elion lists Luma, Commure Engage, and OhMD as similar products; these appear to be a mix of direct and adjacent competitors rather than an established peer set dedicated entirely to inpatient nursing handoffs.

The company was founded in 2024, is a Winter 2024 Y Combinator company listed as active, and has raised $500,000 in pre-seed funding from Y Combinator and Pioneer Fund. Elion reports two verified hospital or health-system customers, Stanford Medicine and Mount Sinai Health System. A third-party Latka profile estimates $440,000 of 2025 revenue, so Kabilah is better characterized as an early commercial company than clearly pre-revenue, although the public evidence does not establish whether that estimate represents recurring paid deployments.